Al's Comment:

 This drug is approved for other cancers so it may be available off label, so if the trial reports success, we can use it right away!


Posted on: 06/15/2020

Karyopharm Announces Dosing of First Patient in a Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Patients with Newly Diagnosed or Recurrent Glioblastoma

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!